Latest DNA vaccination Stories
Texas-based CMO, VGXI engages in mutually beneficial partnership to provide the industry with a unified solution for plasmid manufacturing from preclinical through commercial supply.
DMG Productions explores the latest breakthroughs in health and medicine. The Woodlands, TX (PRWEB) February 12, 2015 VGXI, Inc., announced today that
HERSHEY, Pa., Rockville, Md. and TOKYO, Jan. 29, 2015 /PRNewswire/ -- Immunomic Therapeutics, Inc.
Phase I Trial Reveals DNA Immunotherapy Results Were Similar To HIV-Infected Patients Whose Disease Did Not Progress PLYMOUTH MEETING, Pa., Jan.
Immunomic Therapeutics, Inc., (ITI), and Bioject have entered into an agreement for ITI to use Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ vaccine platform.
VGXI announces the expansion of its state-of-the-art cGMP manufacturing facility, located in The Woodlands, TX. The Woodlands, TX (PRWEB) December 15, 2014
A new hybrid vehicle is under development. Its performance isn’t measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, influenza and other maladies.
PLYMOUTH MEETING, Pa., Nov. 24, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that Dr. J.
PLYMOUTH MEETING, Pa., Nov. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.